Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teun van Gelder

Showing results (1-10 of 324) with videos related to

Pageof 33
Sort By:
Drug Safety|August 9, 2002
Drug interactions with tacrolimusTeun van Gelder
British Journal of Clinical Pharmacology|May 5, 2021
A new method to calculate intra-patient variability in tacrolimus concentrationsTeun van Gelder
Transplantation|August 21, 2018
Placebo-induced Immunosuppression: A Game Changer?Teun van Gelder
Kidney International|May 31, 2014
Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantationTeun van Gelder
Transplant International : Official Journal of the European Society for Organ Transplantation|October 29, 2011
European Society for Organ Transplantation Advisory Committee recommendations on generic substitution of immunosuppressive drugsTeun van Gelder,
Therapeutic Drug Monitoring|January 10, 2023
The Appropriately Designed TDM Clinical Trial: Endpoints, Pitfalls, and PerspectivesTeun van Gelder
Kidney International|July 20, 2021
How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do notTeun van Gelder
Drug Research|November 20, 2018
Pharmacogenetics: The Solution for All Future Challenges?Teun van Gelder
Transplantation|June 8, 2015
What Is the Future of Generics in Transplantation?Teun van Gelder
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2005
Mycophenolate mofetil: how to further improve using an already successful drug?Teun van Gelder
Pageof 33

Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Drug Safety|August 9, 2002
Drug interactions with tacrolimusTeun van Gelder
British Journal of Clinical Pharmacology|May 5, 2021
A new method to calculate intra-patient variability in tacrolimus concentrationsTeun van Gelder
Transplantation|August 21, 2018
Placebo-induced Immunosuppression: A Game Changer?Teun van Gelder
Kidney International|May 31, 2014
Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantationTeun van Gelder
Transplant International : Official Journal of the European Society for Organ Transplantation|October 29, 2011
European Society for Organ Transplantation Advisory Committee recommendations on generic substitution of immunosuppressive drugsTeun van Gelder,
Therapeutic Drug Monitoring|January 10, 2023
The Appropriately Designed TDM Clinical Trial: Endpoints, Pitfalls, and PerspectivesTeun van Gelder
Kidney International|July 20, 2021
How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do notTeun van Gelder
Drug Research|November 20, 2018
Pharmacogenetics: The Solution for All Future Challenges?Teun van Gelder
Transplantation|June 8, 2015
What Is the Future of Generics in Transplantation?Teun van Gelder
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2005
Mycophenolate mofetil: how to further improve using an already successful drug?Teun van Gelder
Pageof 33